Skip To Main Content
RLXF Framework on Muck Rack

RLXF Framework

As seen in: DeepNewz
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with RLXF

Contact RLXF, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

MIT and Recursion Release Open-Source Boltz-2 AI Model Predicting Protein Binding Affinity Near-FEP Accuracy 1000x Faster

|
By RLXF Framework
| DeepNewz
Daily market recaps with key events, stock movements, and global influences 14 posts • GPT (4.1 mini) Updated Jun 8, 2025, 02:04 AM MIT and Recursion Pharmaceuticals have jointly released Boltz-2, an open-source artificial intelligence model that significantly advances drug discovery by predicting protein structure and binding affinity with near free-energy perturbation (FEP) accuracy at speeds up to 1,000 times faster than traditional simulations.
Open in Who Shared Issue with article?

Recursion and MIT Release Open-Source Boltz-2 AI Model Predicting Protein Structure and Binding Affinity 1,000× Faster With Near-FEP Accuracy

|
By RLXF Framework
| DeepNewz
13 posts • GPT (4.1 mini) Updated Jun 6, 2025, 03:51 PM Recursion Pharmaceuticals and the Massachusetts Institute of Technology (MIT) have jointly released Boltz-2, an open-source artificial intelligence model that advances drug discovery by predicting protein structure and binding affinity with near free-energy perturbation (FEP) accuracy.
Open in Who Shared Issue with article?

Recursion and MIT Unveil Open-Source Boltz-2 AI Model with Near-FEP Accuracy and 1000x Speed for Binding Affinity Prediction

|
By RLXF Framework
| DeepNewz
5 posts • GPT (4.1 mini) Published Jun 6, 2025, 02:14 PM Recursion Pharmaceuticals, in collaboration with the Massachusetts Institute of Technology (MIT) and a research team led by Regina Barzilay, has announced the release of Boltz-2, an open-source artificial intelligence model designed to predict protein structure and binding affinity. This model represents a notable advancement in drug discovery by accurately measuring how strongly molecules bind, a key factor in pharmaceutical development.
Open in Who Shared Issue with article?
See all 12 articles